一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
Chinese English Japanese Germany Korea
010-86108875
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Ruxolitinib
941678-49-5

Ruxolitinib synthesis

3synthesis methods
Ruxolitinib, also known as INC424 and INCB18424 or INCB018424, is an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.
Synthetic Routes
  • ROUTE 1
  • 202112078496601656.jpg

    Lin, Qiyan; Meloni, David; Pan, Yongchun; Xia, Michael; Rodgers, James; Shepard, Stacey; Li, Mei; Galya, Laurine; Metcalf, Brian; Yue, Tai-Yuen; Liu, Pingli; Zhou, Jiacheng. Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-?Michael reaction. Jiacheng. Organic Letters. Volume 11. Issue 9. Pages 1999-2002. Journal. (2009).

  • ROUTE 2
  • 202112072099909267.jpg

    Anon. Processes for preparing (S-?(3R)?-?3-?Cyclopentyl-?3-?[4-?(7H-?pyrrolo[2,?3-?d]?pyrimidin-?4-?yl)?-?1H-?pyrazol-?1-?yl]?propanenitrile. IP.com Journal. Volume 13. Issue 1B. Pages 10. Journal; Patent. (2013).

  • ROUTE 3
  • 202112078747884965.jpg

    Haydl, Alexander M.; Xu, Kun; Breit, Bernhard. Regio- and Enantioselective Synthesis of N-?Substituted Pyrazoles by Rhodium-?Catalyzed Asymmetric Addition to Allenes. Angewandte Chemie, International Edition. Volume 54. Issue 24. Pages 7149-7153. Journal; Online Computer File. (2015).

  • ROUTE 4
  • 202112079099039802.jpg

    : Cao, Biao; Zhu, Hanghang; Wu, Jianzhong; Tian, Guanghui. Intermediate of JAK inhibitor and preparation method thereof. Assignee?Suzhou Vigonvita Life Sciences Co., Ltd., Peop. Rep. China. CN?107759623. (2018).

  • ROUTE 5
  • 202112078282502323.jpg

    : Zhang, Xiquan; Zhang, Aiming; Zhou, Zhou; Yang, Leilei; Yao, Huadong; Zhu, Xueyan; Wang, Hubo. Process for synthesis of ruxolitinib. Assignee?Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Peop. Rep. China. WO?2017114461. (2017).

  • ROUTE 6
  • 202112078870938364.jpg

    Hamdy, Ahmed; Rothbaum, Wayne; Izumi, Raquel; Lannutti, Brian; Covey, Todd; Ulrich, Roger; Johnson, Dave; Barf, Tjeerd; Kaptein, Allard. Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, a PD-1 inhibitor and/or a PD-L1 inhibitor. Assignee?Acerta Pharma B.V., Neth. WO?2016024228. (2016).

  • ROUTE 7
  • 202112076208114797.jpg

    Albrecht, Wolfgang; Selig, Roland. Process of preparing oxalate salt of ruxolitinib. Assignee?Ratiopharm GmbH, Germany. WO?2016026974. (2016).

  • ROUTE 8
  • 202112078993099357.jpg

    : Zhou, Jiacheng; Liu, Pingli; Lin, Qiyan; Metcalf, Brian W.; Meloni, David; Pan, Yongchun; Xia, Michael; Li, Mei; Yue, Tai-Yuen; Rodgers, James D.; Wang, Haisheng. Processes for preparing JAKs inhibitors and related intermediate compounds. Assignee?Incyte Corporation, USA. WO?2010083283. (2010).

202112078496601656.jpg

Lin, Qiyan; Meloni, David; Pan, Yongchun; Xia, Michael; Rodgers, James; Shepard, Stacey; Li, Mei; Galya, Laurine; Metcalf, Brian; Yue, Tai-Yuen; Liu, Pingli; Zhou, Jiacheng. Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-?Michael reaction. Jiacheng. Organic Letters. Volume 11. Issue 9. Pages 1999-2002. Journal. (2009).

-

Yield:941678-49-5 100%

Reaction Conditions:

with water;sodium hydroxide in methanol at 20;Product distribution / selectivity;

Steps:

B

(3R)-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propionitrile ((R)-12, free base).; Method B.; To a stirred solution of (4-{1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl}-7H-pyrrolo [2,3-d]pyrimidin-7-yl)methyl pivalate ((R)-21, 376 mg, 0.894 mmol) in methanol (4.0 mL, 99 mmol) at room temperature was added 1.0 M solution of sodium hydroxide in water (NaOH, 179 μL, 0.179 mmol, 2.0 equiv). The reaction mixture was stirred at room temperature for overnight (15 h). When LCMS showed the reaction was done cleanly, the reaction mixture was quenched with water (10 mL) and saturated aqueous NaCl solution (20 mL), and extracted with EtOAc (2×10 mL). The combined organic layers were washed with brine, dried over magnesium sulfate, filtered and concentrated under reduced pressure to afford (3R)-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propionitrile ((R)-12, free base, 274 mg, 274 mg theoretical, 100% yield) as a pale yellow foam, which was found to be identical as the material made from Method A.

References:

US2010/190981,2010,A1 Location in patent:Page/Page column 87-88

Ruxolitinib Related Search:

江北区| 盐山县| 天长市| 政和县| 西盟| 高阳县| 比如县| 科尔| 珲春市| 社旗县| 磐石市| 新兴县| 平远县| 剑阁县| 泰安市| 张家港市| 沾化县| 资溪县| 北票市| 台东市| 西城区| 张家界市| 文安县| 荥经县| 莱阳市| 麻栗坡县| 平潭县| 赣榆县| 海晏县| 汤阴县| 勐海县| 明水县| 图片| 札达县| 上高县| 永兴县| 共和县| 宣武区| 安义县| 新宁县| 东乡族自治县|